Drug Shortage Report for TEVA-PAROXETINE
Report ID | 100550 |
Drug Identification Number | 02248557 |
Brand name | TEVA-PAROXETINE |
Common or Proper name | PAROXETINE 20MG TABLETS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PAROXETINE |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | |
Actual start date | 2019-12-09 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-08-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2022-08-18 | French | Compare |
v6 | 2022-08-18 | English | Compare |
v5 | 2022-01-20 | French | Compare |
v4 | 2022-01-20 | English | Compare |
v3 | 2019-12-10 | English | Compare |
v2 | 2019-12-09 | French | Compare |
v1 | 2019-12-09 | English | Compare |
Showing 1 to 7 of 7